← Back to Screener
Alphatec Holdings, Inc. (ATEC)
Price$10.82
Favorite Metrics
Price vs S&P 500 (26W)-22.53%
Price vs S&P 500 (4W)-14.90%
Market Capitalization$1.73B
All Metrics
P/CF (Annual)38.21x
Book Value / Share (Quarterly)$0.24
P/TBV (Annual)63.76x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)29.62%
Cash Flow / Share (Quarterly)$-0.03
Price vs S&P 500 (YTD)-48.36%
Gross Margin (TTM)69.60%
Net Profit Margin (TTM)-18.76%
EPS (TTM)$-0.96
10-Day Avg Trading Volume2.19M
EPS Excl Extra (TTM)$-0.96
Revenue Growth (5Y)39.45%
EPS (Annual)$-0.96
ROI (Annual)-23.81%
Gross Margin (Annual)69.60%
Net Profit Margin (5Y Avg)-37.33%
Cash / Share (Quarterly)$1.07
Revenue Growth QoQ (YoY)20.44%
ROA (Last FY)-18.12%
Revenue Growth TTM (YoY)24.95%
EBITD / Share (TTM)$-0.55
ROE (5Y Avg)-498.29%
Operating Margin (TTM)-13.05%
Cash Flow / Share (Annual)$-0.03
P/B Ratio47.98x
P/B Ratio (Quarterly)86.75x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)2.79x
Net Interest Coverage (TTM)-2.17x
ROA (TTM)-18.18%
EV / EBITDA (TTM)969.83x
EPS Incl Extra (Annual)$-0.96
Current Ratio (Annual)2.06x
Quick Ratio (Quarterly)1.22x
3-Month Avg Trading Volume2.74M
52-Week Price Return12.18%
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$0.18
P/S Ratio (Annual)2.26x
Asset Turnover (Annual)0.97x
52-Week High$23.29
Operating Margin (5Y Avg)-33.78%
EPS Excl Extra (Annual)$-0.96
CapEx CAGR (5Y)16.50%
Tangible BV CAGR (5Y)-35.23%
26-Week Price Return-18.54%
Quick Ratio (Annual)1.22x
13-Week Price Return-35.08%
Total Debt / Equity (Annual)15.71x
Current Ratio (Quarterly)2.06x
Enterprise Value$2,133.625
Revenue / Share Growth (5Y)18.68%
Asset Turnover (TTM)0.97x
Book Value / Share Growth (5Y)-26.19%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)1.35x
Pretax Margin (Annual)-18.77%
Cash / Share (Annual)$1.07
3-Month Return Std Dev64.83%
Gross Margin (5Y Avg)66.92%
Net Income / Employee (TTM)$-0
ROE (Last FY)-397.90%
Net Interest Coverage (Annual)-0.67x
EPS Basic Excl Extra (Annual)$-0.96
P/FCF (TTM)141.21x
Receivables Turnover (TTM)7.86x
Total Debt / Equity (Quarterly)15.71x
EPS Incl Extra (TTM)$-0.96
Receivables Turnover (Annual)7.86x
ROI (TTM)-15.26%
P/S Ratio (TTM)2.26x
Pretax Margin (5Y Avg)-37.33%
Revenue / Share (Annual)$5.09
Tangible BV / Share (Annual)$0.18
Forward P/E40.08x
Price vs S&P 500 (52W)-17.65%
Year-to-Date Return-45.72%
5-Day Price Return3.16%
EPS Normalized (Annual)$-0.96
ROA (5Y Avg)-23.32%
Net Profit Margin (Annual)-18.76%
Month-to-Date Return4.96%
Cash Flow / Share (TTM)$-1.06
EBITD / Share (Annual)$-0.55
Operating Margin (Annual)-13.05%
LT Debt / Equity (Annual)13.92x
P/CF (TTM)38.21x
ROI (5Y Avg)-31.16%
LT Debt / Equity (Quarterly)13.92x
EPS Basic Excl Extra (TTM)$-0.96
P/TBV (Quarterly)63.76x
P/B Ratio (Annual)86.75x
Inventory Turnover (TTM)1.35x
Pretax Margin (TTM)-18.77%
Book Value / Share (Annual)$0.24
Price vs S&P 500 (13W)-35.76%
Beta1.12x
P/FCF (Annual)383.26x
Revenue / Share (TTM)$5.02
ROE (TTM)-231.50%
52-Week Low$9.80
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.11
4.11
4.11
4.11
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
ATECAlphatec Holdings, Inc. | 2.26x | 39.45% | 69.60% | -13.05% | $10.82 |
SYKStryker Corporation | 5.15x | 11.84% | 64.57% | 19.43% | $338.38 |
BSXBoston Scientific Corp. | 4.76x | 15.16% | 69.01% | 18.00% | $63.42 |
MMM3M Company | 3.18x | -4.97% | 39.92% | 18.55% | $150.55 |
MDLNMedline Inc. Class A common stock | 2.21x | — | 26.44% | 7.78% | $46.94 |
BDXBecton, Dickinson and Co. | 2.01x | 6.32% | 46.42% | 12.15% | $154.82 |
RMDResMed Inc. | 6.06x | 11.72% | 60.85% | 33.70% | $224.72 |
DXCMDexCom, Inc. | 5.23x | 19.33% | 62.09% | 19.56% | $61.23 |
WSTWest Pharmaceutical Services, Inc. | 6.22x | 7.44% | 35.91% | 19.03% | $269.81 |
PODDInsulet Corporation | 5.31x | 24.53% | 71.63% | 12.92% | $201.47 |
PENPenumbra, Inc. | 9.31x | 20.16% | 67.14% | 13.48% | $331.47 |
About
Alphatec Holdings is a medical technology company that develops spine surgery solutions for treating degenerative disc disease, spinal trauma, and congenital deformities. The company offers a portfolio of implants and surgical instruments across multiple fusion approaches—including anterior cervical, lateral interbody, and posterior lumbar procedures—designed to decompress nerves, stabilize the spine, and restore proper alignment. Its diverse product platform addresses a large and growing market for spinal surgery treatments.